Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
In an unprecedented show of solidarity, Bologna FC 1909 has announced that half of the proceeds from its upcoming match ...
Savannah Chrisley is opening up about her life after her parents Todd and Julie Chrisley's imprisonment, and sharing her hope ...
Following a $7.5 million raise led by Hashed and Tribe Capital, Blueprint Finance, emerging from stealth, today announces Concrete Protocol, ...
The Basic is Ring’s cheapest plan and gives you access to cloud storage of recorded videos from one camera or ...
Copyright © 2024 The Israel Chronicle News.
The Israel Chronicle News is not responsible for the content of external sites.